Premium
AUTOLOGOUS STEM CELL TRANSPLANT WITH HIGH DOSE MELPHALAN PREPARATIVE REGIMEN IS SAFE AND EFFECTIVE FOR ELDERLY MULTIPLE MYELOMA PATIENTS IN THE ERA OF TRIPLE INDUCTION THERAPY
Author(s) -
Czyz A.,
RomejkoJarosinska J.,
Szeremet A.,
BoguckaFedorczuk A.,
Majcherek M.,
Szymanski M.,
Walewski J.,
Wrobel T.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.238_2631
Subject(s) - medicine , melphalan , multiple myeloma , regimen , autologous stem cell transplantation , bortezomib , thalidomide , cyclophosphamide , retrospective cohort study , surgery , dexamethasone , oncology , chemotherapy